TMCI
Treace Medical Concepts Inc
NASDAQ: TMCI · HEALTHCARE · MEDICAL DEVICES
$1.81
+1.69% today
Updated 2026-04-30
Market cap
$123.74M
P/E ratio
—
P/S ratio
0.58x
EPS (TTM)
$-0.93
Dividend yield
—
52W range
$1 – $8
Volume
0.9M
Treace Medical Concepts Inc (TMCI) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-7.67M | $-4.49M | $-17.19M | $-30.65M | $-34.58M | $-37.17M | $-15.97M |
| Capital expenditures | $1.21M | $1.07M | $2.71M | $14.84M | $11.46M | $11.59M | $13.52M |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $815000.00 | $919000.00 | $3.41M | $8.11M | $17.35M | $30.60M | $33.82M |
| Free cash flow | $-8.88M | $-5.56M | $-19.90M | $-45.49M | $-46.03M | $-48.76M | $-29.49M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | $7.93M | — | $0.00 | $0.00 | $0.00 |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | $87.75M | $-86.36M | — | — | — |